Results 131 to 140 of about 6,785 (163)

Highlight of 2025: From binding prediction to molecular design-computational advances in TCR-pMHC prediction and targeting. [PDF]

Immunol Cell Biol
Maire KJ, Coquet JM.
europepmc   +1 more source

Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis. [PDF]

J Immunother Cancer
Gomez-Manzano C, Shin DH, Alvarez-Breckenridge C, Gillard AG, Morad G, Puduvalli VK, Alonso MM, Lang FF, Fueyo J.   +8 more
europepmc   +1 more source

Properties of CD8 T-cell-recognized neoantigens in different tumor types. [PDF]

Immunooncol Technol
Ketelaars SLC, van Buuren MM, Gangaev A, van Rooij N, Patiwael S, Hoefakker K, Fanchi LF, Baas P, van der Heijden M, Kok M, Schumacher TN, Kvistborg P, Haanen JBAG.   +12 more
europepmc   +1 more source

A scientific journey through viral immunology, vaccines, and neuroinflammation. [PDF]

Hum Vaccin Immunother
Klavinskis LS.
europepmc   +1 more source

Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting. [PDF]

PLoS Pathog
Seow J, Jefferson GCE, Keegan MD, Yau Y, Snell LB, Doores KJ.   +5 more
europepmc   +1 more source

Antibodies, Memory B Cells, and Antigen Valency Reshape B Cell Responses to Drifted Influenza Virus Vaccination

Reusch L, Mathew NR, Schön K, Kosik I, Gibbs JS, Mankowski MC, Besavilla DF, Yewdell JW, Bemark M, Angeletti D.   +9 more
europepmc   +1 more source

Immunodominant Tuberculosis Antigens Recognized by Human CD4⁺ and CD8⁺ T Cells. [PDF]

Cold Spring Harb Perspect Med
Lewinsohn DA, Lindestam Arlehamn CS, Sette A, Lewinsohn DM.   +3 more
europepmc   +1 more source

Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses. [PDF]

Elife
Deng Y, Tang M, Ross TM, Schmidt AG, Chakraborty AK, Lingwood D.   +5 more
europepmc   +1 more source

Oncolytic immunovirotherapy: finding the tumor antigen needle in the antiviral haystack. [PDF]

Immunotherapy
Kendall BL, Vile RG.
europepmc   +1 more source

Advances in the Development of a Universal Influenza Vaccine. [PDF]

Antibodies (Basel)
Mudaly P, Lee M, Bhatta A, Thompson C.
europepmc   +1 more source